MedPath
FDA Approval

NP Thyroid 60

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Asclemed USA, Inc.
DUNS: 059888437
Effective Date
May 16, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Levothyroxine(38 ug in 1 1)
Liothyronine(9 ug in 1 1)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

ASCLEMED USA INC. DBA ENOVACHEM

Asclemed USA, Inc.

059888437

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

NP Thyroid 60

Product Details

NDC Product Code
76420-568
Route of Administration
ORAL
Effective Date
May 16, 2023
MINERAL OILInactive
Code: T5L8T28FGPClass: IACT
Code: Q51BO43MG4Class: ACTIBQuantity: 38 ug in 1 1
Code: 06LU7C9H1VClass: ACTIBQuantity: 9 ug in 1 1
CALCIUM STEARATEInactive
Code: 776XM7047LClass: IACT
DEXTROSE MONOHYDRATEInactive
Code: LX22YL083GClass: IACT
© Copyright 2025. All Rights Reserved by MedPath